Page last updated: 2024-10-17

2-aminoadipic acid and Myocardial Infarction

2-aminoadipic acid has been researched along with Myocardial Infarction in 2 studies

2-Aminoadipic Acid: A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; (NMDA).
2-aminoadipic acid : An alpha-amino acid that is adipic acid bearing a single amino substituent at position 2. An intermediate in the formation of lysine.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asanuma, H1
Sanada, S1
Ogai, A1
Minamino, T1
Takashima, S1
Asakura, M1
Ogita, H1
Shinozaki, Y1
Mori, H1
Node, K1
Tomoike, H1
Hori, M1
Kitakaze, M1
Olszewski, AJ1
Szostak, WB1

Other Studies

2 other studies available for 2-aminoadipic acid and Myocardial Infarction

ArticleYear
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
    Journal of cardiovascular pharmacology, 2004, Volume: 43, Issue:4

    Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarctio

2004
Homocysteine content of plasma proteins in ischemic heart disease.
    Atherosclerosis, 1988, Volume: 69, Issue:2-3

    Topics: 2-Aminoadipic Acid; Adult; Amino Acids; Blood Proteins; Homocysteine; Humans; Male; Middle Aged; Myo

1988